XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stock based compensation | 9 Months Ended
--- | ---
Dec. 31, 2018
Share-based Compensation [Abstract] |
Stock based compensation | As disclosed in Note 17, on October 6, 2017, the Company issued restricted stock awards totaling 3,900,000 shares of its common stock to 16 employees and awarded nonqualified stock options to purchase an aggregate of 360,000 shares of its common stock at a strike price $1.98 per share to two employees. Shares of restricted stock have the same dividend and voting rights as common stock while options do not. All awards were issued at the fair value of the underlying shares at the grant date. During the year ended March 31, 2018, stock options covering a total of 360,000 shares of common stock were granted. No options were granted during the three and nine month periods ended December 31, 2018. Total compensation expense related to options granted was $54 for the three months ended December 31, 2018, and $51 for the three months ended December 31, 2017. Total compensation expense related to options granted for the nine months periods ended December 31, 2018 and 2017, was $162 and $51, respectively. As of December 31, 2018, there was total remaining compensation expense of $381 related to stock options, which will be recorded over a weighted average period of approximately 1.76 years. The Company has determined the fair value of such stock options using the Black-Scholes option valuation model based on the following key assumptions:
Vesting period (years) | 3
Volatility | 165.33%
Risk-free rate | 1.66%
During the year ended March 31, 2018, a total of 3,900,000 shares of common stock were awarded. During the three and nine months ended December 31, 2018, no shares of common stock were awarded. The compensation expense related to restricted stock grants was $793 during the three months ended December 31, 2018, and $741 during the three months ended December 31, 2017. Total compensation expense related to restricted stock grants was $2,371 and $741 during the nine months ended December 31, 2018 and 2017, respectively. As of December 31, 2018, there was $4,298 of total unrecognized compensation cost related to nonvested shares of common stock granted. The cost is expected to be recognized over a weighted average period of 1.54 years. Stock-based compensation expense for the cost of the awards granted is based on the grant-date fair value. For stock option awards, the fair value is estimated at the date of grant using the Black-Scholes option-pricing model. This model requires the input of highly subjective assumptions, changes to which can materially affect the fair value estimate. Additionally, there may be other factors that would otherwise have a significant effect on the value of employee stock options granted but are not considered by the model. Accordingly, while management believes that the Black-Scholes option-pricing model provides a reasonable estimate of fair value, the model does not necessarily provide the best single measure of fair value for the Company's employee stock options. During the three months ended December 31, 2018, 10,000 stock options were exercised. The following is a summary of stock option activity for the nine months ended December 31, 2018:
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (In Years) |  |  | Aggregate Intrinsic Value |
Outstanding, March 31, 2018 |  |  | 360,000 |  |  | $ | 1.98 |  |  |  | 9.52 |  |  | $ | 1,753 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (10,000 | ) |  |  | 1.98 |  |  |  | - |  |  |  | 66 |
Forfeited/cancelled/expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding, at December 31, 2018 |  |  | 350,000 |  |  | $ | 1.98 |  |  |  | 8.76 |  |  | $ | 2,198 |
Exercisable, at December 31, 2018 |  |  | 110,000 |  |  | $ | 1.98 |  |  |  | 8.76 |  |  | $ | 691 |
The table below summarizes the activity for the Company's restricted stock outstanding during the nine months ended December 31, 2018:
|  | Shares |  |  | Weighted Average Fair Value |
Outstanding, March 31, 2018 |  |  | 3,900,000 |  |  | $ | 8,190 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | 1,500,000 |  |  |  | 3,150 |
Forfeited/cancelled/expired |  |  | - |  |  |  | - |
Outstanding, at December 31, 2018 |  |  | 2,400,000 |  |  | $ | 5,040 |

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration